IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 139 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2024. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $19,551,920 | 32.71% |
| STEMPOINT CAPITAL LP | 339,351 | $11,500,605 | 3.38% |
| RTW INVESTMENTS, LP | 4,869,798 | $165,037,454 | 2.56% |
| Eschler Asset Management LLP | 40,000 | $2,600,000 | 2.04% |
| CANTOR FITZGERALD, L. P. | 254,027 | $8,608,975 | 1.70% |
| First Turn Management, LLC | 291,086 | $9,864,905 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $13,745,784 | 1.40% |
| GENERAL ATLANTIC, L.P. | 1,261,684 | $42,758,471 | 1.34% |
| BRAIDWELL LP | 797,268 | $27,019,413 | 0.85% |
| Baker Brothers Advisors | 1,515,318 | $51,354,127 | 0.66% |
| Bellevue Group AG | 1,154,654 | $39,131,224 | 0.64% |
| HealthInvest Partners AB | 23,778 | $805,836 | 0.49% |
| Rock Springs Capital Management LP | 419,030 | $14,200,927 | 0.43% |
| ARMISTICE CAPITAL, LLC | 976,000 | $33,076,640 | 0.42% |
| Pier Capital, LLC | 81,306 | $2,755,460 | 0.41% |
| Avidity Partners Management LP | 200,000 | $6,778,000 | 0.29% |
| Eagle Health Investments LP | 46,300 | $1,569,107 | 0.28% |
| Nan Fung Group Holdings Ltd | 6,750 | $228,758 | 0.24% |
| Rhenman & Partners Asset Management AB | 58,278 | $1,975,041 | 0.19% |
| Frazier Life Sciences Management, L.P. | 108,762 | $3,685,944 | 0.17% |
External links
This page lists IMMUNOCORE HLDGS PLC's shareholders in Q2 2024. To view IMMUNOCORE HLDGS PLC's shareholder history, click here.